HIGHLIGHTS
- who: Shangwen Lei from the nggang West Road, Lanzhou, Peopleu2019s Republic of China have published the article: Efficacy and safety of progressively reducing biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis in persistent remission: a study protocol for a non-inferiority randomized, controlled, single-blind trial, in the Journal: (JOURNAL) of 26/03/2021
- what: At present, most of the existing studies focused on the reduction and withdrawal strategies of tumor necrosis factors (TNF) inhibitors, and few of them reported other types of biological agents.
SUMMARY
When patients get . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.